Qlucore AB (QCORE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Qlucore AB (QCORE) has a cash flow conversion efficiency ratio of -0.064x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.56 Million ≈ $-274.96K USD) by net assets (Skr39.65 Million ≈ $4.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Qlucore AB - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Qlucore AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read QCORE total debt and obligations for a breakdown of total debt and financial obligations.
Qlucore AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qlucore AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Treatt PLC
LSE:TET
|
0.020x |
|
Bohra Industries Limited
NSE:BOHRAIND
|
0.009x |
|
Ace Integrated Solutions Limited
NSE:ACEINTEG
|
0.005x |
|
Nilsson Special Vehicles publ AB
ST:NILS
|
-1.318x |
|
Clearside Biomedical Inc
NASDAQ:CLSD
|
0.102x |
|
Direct Digital Holdings Inc
NASDAQ:DRCT
|
0.266x |
|
Afentra PLC
LSE:AET
|
0.408x |
|
British Smaller Companies Vct 2 Plc
LSE:BSC
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Qlucore AB (2019–2025)
The table below shows the annual cash flow conversion efficiency of Qlucore AB from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see QCORE market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-04-30 | Skr58.47 Million ≈ $6.29 Million |
Skr-14.15 Million ≈ $-1.52 Million |
-0.242x | -13.00% |
| 2024-04-30 | Skr79.11 Million ≈ $8.51 Million |
Skr-16.95 Million ≈ $-1.82 Million |
-0.214x | -152.16% |
| 2023-04-30 | Skr94.73 Million ≈ $10.19 Million |
Skr-8.05 Million ≈ $-866.20K |
-0.085x | -38.02% |
| 2022-04-30 | Skr110.56 Million ≈ $11.90 Million |
Skr-6.81 Million ≈ $-732.43K |
-0.062x | -108.40% |
| 2021-04-30 | Skr36.56 Million ≈ $3.93 Million |
Skr-1.08 Million ≈ $-116.23K |
-0.030x | -126.46% |
| 2020-04-30 | Skr14.34 Million ≈ $1.54 Million |
Skr1.60 Million ≈ $172.29K |
0.112x | -40.31% |
| 2019-04-30 | Skr8.56 Million ≈ $921.47K |
Skr1.60 Million ≈ $172.29K |
0.187x | -- |
About Qlucore AB
Qlucore AB (publ) offers visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. It offers Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a software platform for m… Read more